BioVie Inc
BIVI
NASDAQ
Biotechnology
$1.40
USD
-0.16 (-10.26%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $11.88M
Volume 2.0M
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
BIVI | BioVie Inc | $11.88M | - | - | - | |
MTVA | MetaVia Inc | $9.62M | - | - | - | |
IMNN | Imunon Inc | $8.81M | - | - | - | |
CELZ | Creative Medical Technology Holdings Inc | $8.17M | - | -78.6% | - | |
LIMN | Liminatus Pharma Inc | $7.86M | - | - | - | |
FBLG | Fibrobiologics Inc | $7.66M | - | - | - | |
ALZN | Alzamend Neuro Inc | $7.00M | - | - | - | |
ACXP | Acurx Pharmaceuticals Inc | $6.36M | - | - | - | |
BOLT | Bolt Biotherapeutics Inc | $6.18M | - | +78.6% | - | |
ENSC | Ensysce Biosciences Inc | $5.23M | - | -24.4% | - | |
CRIS | Curis Inc | $3.64M | - | -37.0% | - |
Top Peer by Growth
Vistagen Therapeutics Inc
+15.3% YoY Revenue
Best 1-Year Return
BioVie Inc
-6.6% Return